rofix 400 capsules capsule, hard
pharma plus kenya limited machakos, block 11/263 ngei road, kenya - cefixime trihydrate - capsule, hard - each capsule contains cefixime trihydrate usp - beta-lactamantibacterials: second-generation
cefixime 200 mg film-coated tablets
orchid europe limited - cefixime - film-coated tablet - 200 milligram(s) - other beta-lactam antibacterials
taxim-o 400 mg capsules
alkem laboratories ltd alkem house, “devashish”, senapati bapat marg, - cefixime trihydrate usp - capsule - each capsule contains: cefixime (as trihydrate) - cefixime
evercef 200 tablets film-coated tablet
laboratory & allied ltd plot no. 209/10349,mombasa road. p.o box - cefixime trihydrate - film-coated tablet - each film coated tablet contains: cefixime - cefixime
evercef 400 tablets film-coated tablet
laboratory & allied ltd plot no. 209/10349,mombasa road.p.o box - cefixime trihydrate - film-coated tablet - each film coated tablet contains: cefixime - cefixime
sanix - ds 100 powder for oral suspension
vi/51b, p.b no.2, kozhuvanal, pala, kottayam vi/51b, p.b no.2, kozhuvanal, pala, kottayam - cefixime trihydrate - powder for oral suspension - 100mg/5ml, cefixime - usp - cefixime
sefixi 200 capsule
cefixime capsules - capsule - cefixime trihydrate usp equivalent to anhydrous - cefixime
sefixi 50 dry syrup powder for oral suspension
cefixime for oral suspension usp - powder for oral suspension - cefixime trihydrate usp eq. to anhydrous - cefixime
suprax- cefixime capsule
pd-rx pharmaceuticals, inc. - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 400 mg - suprax is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated urinary tract infections caused by susceptible isolates of escherichia coli and proteus mirabilis . suprax is indicated in the treatment of adults and pediatric patients six months of age or older with otitis media caused by susceptible isolates of haemophilus influenzae , moraxella catarrhalis , and streptococcus pyogenes. (efficacy for streptococcus pyogenes in this organ system was studied in fewer than 10 infections.) note: for patients with otitis media caused by streptococcus pneumoniae , overall response was approximately 10% lower for cefixime than for the comparator [see clinical studies ( 14)]. suprax is indicated in the treatment of adults and pediatric patients six months of age or older with pharyngitis and tonsillitis caused by susceptible isol
suprax- cefixime powder, for suspension
lupin pharmaceuticals, inc. - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 100 mg in 5 ml - suprax is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated urinary tract infections caused by susceptible isolates of escherichia coli and proteus mirabilis . suprax is indicated in the treatment of adults and pediatric patients six months of age or older with otitis media caused by susceptible isolates of haemophilus influenzae , moraxella catarrhalis , and streptococcus pyogenes. (efficacy for streptococcus pyogenes in this organ system was studied in fewer than 10 infections.) note: for patients with otitis media caused by streptococcus pneumoniae , overall response was approximately 10% lower for cefixime than for the comparator [see clinical studies (14)] . suprax is indicated in the treatment of adults and pediatric patients six months of age or older with pharyngitis and tonsillitis caused by susceptible isolates of streptococcus pyogenes. (note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes infections.